HEALTHEQUITY, INC. (HQY) Stock Analysis
HEALTHEQUITY, INC. (HQY) Stock Analysis
Overall Grade: F (Concerning)
View interactive company profile →
HEALTHEQUITY, INC. faces challenges in financial performance that warrant careful analysis.
Key Metrics:
| Metric | Value | Context |
|---|---|---|
| ROIC | 6.4% | Below expectations |
| FCF Margin | 28.8% | Strong cash generation |
| Debt/Equity | 0.5x | Conservative leverage |
Investment Thesis: Healthy free cash flow margin of 28.8% provides financial flexibility for growth and shareholder returns.
What is HEALTHEQUITY, INC.'s Profitability and ROIC?
HEALTHEQUITY, INC.'s return on invested capital of 6.4% is below the typical cost of capital. Gross margin of 66.4% with operating margin at 18.5% reflects the company's strong market position.
Key Metrics
| Metric | Value | Rating | Interpretation |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 6.4% | Warning | Below cost of capital |
| Return on Equity (ROE) | 6.9% | Warning | Moderate equity returns |
| Gross Margin | 66.4% | Excellent | Strong pricing power |
| Operating Margin | 18.5% | Good | Efficient operations |
How Strong is HEALTHEQUITY, INC.'s Cash Flow Quality?
HEALTHEQUITY, INC. generated $365.4M in free cash flow over the trailing twelve months, representing a 28.8% margin. Cash earnings quality is strong, with operating cash flow exceeding net income by 2.5x.
Key Metrics
| Metric | Value | Rating | Interpretation |
|---|---|---|---|
| Free Cash Flow Margin | 28.8% | Excellent | Excellent cash conversion |
| Free Cash Flow (TTM) | $365.4M | Good | Positive cash generation |
| OCF/Net Income | 2.5x | Excellent | High earnings quality |
| FCF Consistency (8Q) | N/A | Warning | Variable cash flow |
What is HEALTHEQUITY, INC.'s Financial Health?
HEALTHEQUITY, INC.'s debt-to-equity ratio of 0.5x indicates conservative leverage.
Key Metrics
| Metric | Value | Rating | Interpretation |
|---|---|---|---|
| Debt to Equity | 0.5x | Good | Conservative capital structure |
| Net Cash Position | $-702.4M | Adequate | Net debt position |
Is HEALTHEQUITY, INC. Stock Overvalued or Undervalued?
HEALTHEQUITY, INC. trades at a P/E of 57.7x, representing a premium to the sector median of N/A.
Key Metrics
| Metric | Value | Rating | Interpretation |
|---|---|---|---|
| P/E Ratio | 57.7x | Warning | Premium valuation |
| EV/Sales | 6.9x | Adequate | Growth premium priced in |
Sector Rankings
| Metric | Value | Percentile | vs Median |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 6.4% | Bottom 50% | 1.0x below |
| Free Cash Flow Margin | 28.8% | Top 25% | 2.9x above |
| Gross Margin | 66.4% | Top 50% | 1.3x above |
| Operating Margin | 18.5% | Top 25% | 2.9x above |
| Return on Equity (ROE) | 6.9% | Top 50% | 1.1x above |
| P/E Ratio | 57.7x | N/A | - |
Rating Thresholds
Return on Invested Capital (ROIC)
Measures how efficiently a company uses its debt and equity capital to generate profits. ROIC above 15% typically indicates a competitive moat.
| Rating | Range | Interpretation |
|---|---|---|
| Excellent | > 20% | Exceptional capital efficiency, strong competitive moat |
| Good | 12% - 20% | Above-average returns, sustainable competitive position |
| Adequate | 8% - 12% | Around cost of capital, moderate competitive position |
| Warning | 4% - 8% | Below cost of capital, value may be eroding |
| Red flag | < 4% | Significant capital destruction, fundamental issues |
Current: 6.4% (Warning - Bottom 50% of sector (median: 6.5%))
Free Cash Flow Margin
The percentage of revenue converted to free cash flow. Higher margins indicate stronger cash generation and business quality.
| Rating | Range | Interpretation |
|---|---|---|
| Excellent | > 20% | Strong cash generation, high-quality business |
| Good | 10% - 20% | Healthy cash conversion |
| Adequate | 5% - 10% | Moderate cash generation |
| Warning | 0% - 5% | Thin cash margins, capital intensive |
| Red flag | < 0% | Cash burn, potential liquidity concerns |
Current: 28.8% (Excellent - Top 25% of sector (median: 10.0%))
Gross Margin
Revenue minus cost of goods sold as a percentage. Higher gross margins indicate pricing power and competitive advantage.
| Rating | Range | Interpretation |
|---|---|---|
| Excellent | > 50% | Strong pricing power and competitive moat |
| Good | 30% - 50% | Healthy margins, differentiated product |
| Adequate | 20% - 30% | Moderate margins, competitive industry |
| Warning | 10% - 20% | Thin margins, commodity-like business |
| Red flag | < 10% | Very thin margins, structural challenges |
Current: 66.4% (Excellent - Top 50% of sector (median: 52.9%))
Debt to Equity Ratio
Total debt divided by shareholders' equity. Lower ratios indicate more conservative financing and reduced financial risk.
| Rating | Range | Interpretation |
|---|---|---|
| Excellent | < 0.3x | Conservative leverage, strong balance sheet |
| Good | 0.3x - 0.7x | Moderate leverage, healthy financial position |
| Adequate | 0.7x - 1.5x | Elevated leverage, monitor closely |
| Warning | 1.5x - 3.0x | High leverage, increased financial risk |
| Red flag | > 3.0x | Excessive leverage, potential distress risk |
Current: 46.9% (Good)
P/E Ratio (Price-to-Earnings)
Stock price divided by earnings per share. Lower P/E may indicate undervaluation, while higher P/E suggests growth expectations.
| Rating | Range | Interpretation |
|---|---|---|
| Excellent | < 15x | Attractively valued, potential opportunity |
| Good | 15x - 25x | Fair value for quality company |
| Adequate | 25x - 35x | Growth premium, justify with earnings growth |
| Warning | 35x - 50x | High expectations priced in |
| Red flag | > 50x or negative | Speculative valuation or losses |
Current: 57.7x (Warning)
Frequently Asked Questions
Q: What is HEALTHEQUITY, INC.'s Return on Invested Capital (ROIC)?
HEALTHEQUITY, INC. (HQY) has a trailing twelve-month Return on Invested Capital (ROIC) of 6.4%. This compares below the sector median of 6.5%. An ROIC below 8% suggests the company may be destroying shareholder value.
Q: What is HEALTHEQUITY, INC.'s Free Cash Flow Margin?
HEALTHEQUITY, INC. (HQY) has a free cash flow margin of 28.8%, generating $365.4 million in free cash flow over the trailing twelve months. A FCF margin above 20% indicates excellent cash conversion and a high-quality business model.
Q: Is HEALTHEQUITY, INC. stock overvalued or undervalued?
HEALTHEQUITY, INC. (HQY) trades at a P/E ratio of 57.7x, which is above the sector median of N/A. The EV/Sales multiple is 6.9x.
Q: Is HEALTHEQUITY, INC. buying back stock?
HEALTHEQUITY, INC. (HQY) repurchased $247.3 million of stock over the trailing twelve months.
Q: How does HEALTHEQUITY, INC. compare to competitors in Technology?
Compared to other companies in Technology, HEALTHEQUITY, INC. (HQY) shows: ROIC of 6.4% is below the sector median of 6.5% (Bottom 49%). FCF margin of 28.8% exceeds the sector median of 10.0% (Top 16% of sector). Gross margin at 66.4% is 13.5 percentage points higher than sector peers. These rankings are based on MetricDuck's analysis of all Technology companies with available SEC filings.
Q: What warning signs should I watch for with HEALTHEQUITY, INC.?
HEALTHEQUITY, INC. (HQY) shows no major financial warning signs based on current metrics. However, investors should always monitor: 1) Margin compression trends, 2) Cash flow consistency, 3) Debt levels relative to cash generation, and 4) Changes in competitive positioning.
Data Source: Data sourced from 10-Q filed 2025-12-03. TTM metrics as of Q3 2025.
Methodology: Financial metrics calculated from SEC 10-K and 10-Q filings using standardized formulas. Sector comparisons use peer group based on SIC code.
This analysis is for informational purposes only and does not constitute investment advice.